These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


184 related items for PubMed ID: 22522778

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
    Kazerooni T, Dehghan-Kooshkghazi M.
    Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.
    Kolodziejczyk B, Duleba AJ, Spaczynski RZ, Pawelczyk L.
    Fertil Steril; 2000 Jun; 73(6):1149-54. PubMed ID: 10856473
    [Abstract] [Full Text] [Related]

  • 7. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
    Genazzani AD, Lanzoni C, Ricchieri F, Baraldi E, Casarosa E, Jasonni VM.
    Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
    [Abstract] [Full Text] [Related]

  • 8. [Rosuvastatin and metformin decrease inflammation and oxidative stress in patients with hypertension and dyslipidemia].
    Gómez-García A, Martínez Torres G, Ortega-Pierres LE, Rodríguez-Ayala E, Alvarez-Aguilar C.
    Rev Esp Cardiol; 2007 Dec; 60(12):1242-9. PubMed ID: 18082089
    [Abstract] [Full Text] [Related]

  • 9. Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.
    Puurunen J, Piltonen T, Puukka K, Ruokonen A, Savolainen MJ, Bloigu R, Morin-Papunen L, Tapanainen JS.
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4798-807. PubMed ID: 24152688
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP, Moran LJ.
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ultrasonography modifications of visceral and subcutaneous adipose tissue after pioglitazone or glibenclamide therapy combined with rosuvastatin in type 2 diabetic patients not well controlled by metformin.
    Maffioli P, Fogari E, D'Angelo A, Perrone T, Derosa G.
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1113-22. PubMed ID: 23524525
    [Abstract] [Full Text] [Related]

  • 18. [Study on treatment of hyperandrogenism and hyperinsulinism in polycystic ovary syndrome with Chinese herbal formula "tiangui fang"].
    Hou J, Yu J, Wei M.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2000 Aug; 20(8):589-92. PubMed ID: 11789189
    [Abstract] [Full Text] [Related]

  • 19. Effects of simvastatin and metformin on polycystic ovary syndrome after six months of treatment.
    Banaszewska B, Pawelczyk L, Spaczynski RZ, Duleba AJ.
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3493-501. PubMed ID: 21865358
    [Abstract] [Full Text] [Related]

  • 20. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X, Lin JF.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 07; 85(46):3266-71. PubMed ID: 16409817
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.